Fusion Pharmaceuticals Inc.
USD21.55
+0.03 (+0.14%)
CEO
John F. Valliant
IPO Date
2020-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$21.55
Prev. Close
$21.52
Day Low
$21.48
Day High
$21.58
52W Low
$2.31
52W High
$21.60
Market Cap
$1.83B
Volume
6.08M
| 17,000 |
| $8.15 |
| 4 Jun 2024 | Duncan Barbara Gayle | director | D-Return | Disposed | 17,000 | $3.60 |
| 4 Jun 2024 | Duncan Barbara Gayle | director | D-Return | Disposed | 17,000 | $4.64 |
| 4 Jun 2024 | Bergstrom Donald A | director | D-Return | Disposed | 17,000 | $8.15 |
| 4 Jun 2024 | Bergstrom Donald A | director | D-Return | Disposed | 34,000 | $10.59 |
| 4 Jun 2024 | Bergstrom Donald A | director | D-Return | Disposed | 17,000 | $3.60 |
| 4 Jun 2024 | Bergstrom Donald A | director | D-Return | Disposed | 17,000 | $4.64 |
| 4 Jun 2024 | Meek David D. | director | D-Return | Disposed | 34,000 | $4.16 |
| 4 Jun 2024 | Valliant John | director, officer: Chief Executive Officer | D-Return | Disposed | 318,147 | $21.00 |